跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ORLADEYO 150 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ORLADEYO 150 MG CAPSULAS DURAS
Approved
STANDARD
ORLADEYO 150 MG CAPSULAS DURAS
Biocryst Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 30, 2022
Approval ID
b7459e1f7acb8e05
Company
Biocryst Ireland Limited
Type
Standard
Approval Details
Approval Id
b7459e1f7acb8e05
Drug Cima Aemps Name
ORLADEYO 150 MG CAPSULAS DURAS
Register Number
1211544001
Holder Company Name
Biocryst Ireland Limited
Marketing Company Name
Biocryst Ireland Limited
Holder Company Detail Path
/organization/biocryst-ireland-ltd
Marketing Company Detail Path
/organization/biocryst-ireland-ltd
Authorization Date
2022-11-30
Dosage Form
CÁPSULA DURA
Dose
150 MG
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Biocryst Ireland Limited
Company Detail Path
/organization/biocryst-ireland-ltd
Company Information
Pharmaceutical Company Name
BioCryst Ireland Ltd.
Country Name
Ireland
Active Ingredients
BEROTRALSTAT DIHIDROCLORURO
172,41 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 30, 2022
Approval ID
b7459e1f7acb8e05
Type
Standard
Back to CIMA-AEMPS Approvals